Navigation Links
Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
Date:7/1/2008

he American Foundation for Aging Research, The Gladstone Institute of Neurological Disease at The University of California Medical School, and The Center for Neurodegenerative Disease at Brigham and Women's Hospital to name a few. Dr. Goldberg has published nearly 400 scientific articles and is an inventor on numerous patents.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present and future clinical trials and results of such trials, plans and objectives for regulatory approval, litigation, intellectual property, product development, manufacturing plans and performance such as the anticipated growth in the monoclonal antibody market and our other target markets and projected growth in product sales, constitute forward-look
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Repligen Announces Share Repurchase Program
2. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
3. Repligen Elects Earl Henry, M.D. to the Board of Directors
4. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
5. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
6. East Jefferson General Hospital Selects Allscripts Electronic Health Record, Offers Free Electronic Prescribing for Affiliated New Orleans-Area Physicians
7. The University of Toledo selects SXC Health Solutions (informedRx) to provide pharmacy benefit management services
8. Michigan Health & Hospital Association Elects 2008 Officers and Board Members, Bestows Awards
9. Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program
10. District of Columbia Primary Care Association Selects Microsoft Amalga to Improve Patient Care for the Underserved
11. Martin Memorial Health Systems Selects Allscripts for Electronic Health Record and Practice Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... the first genetic variant specifically associated with the ... around 10-15 per cent of all breast cancer ... breast cancer sub-type, called invasive lobular carcinoma, gives ... this particular kind of breast cancer, which can ... today (Thursday) in the journal PloS Genetics ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... New Rochelle, NY, April 17, 2014U.S. military personnel ... "blast plus impact" concussive traumatic brain injury (TBI) ... were evacuated for other medical reasons. Differences in ... and depression 6-12 months after injury are reported ... , a peer-reviewed journal from Mary Ann Liebert, ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood ... at UC Irvine and the Salk Institute have opened ... prevent stroke-induced brain damage. , A complex and devastating ... and primary reason for disability in the U.S. The ... lets blood-borne material into the brain, causing the permanent ...
(Date:4/17/2014)... Cesar A. Arias, M.D., Ph.D., at The University of ... a new superbug that caused a bloodstream infection in ... 17 issue of The New England Journal of ... a class of highly-resistant bacteria known as methicillin-resistant ... cause of hospital and community-associated infections. The superbug has ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2
... Technologies Inc.,(TSX: NDQ), a developer of real-time imaging and image ... results for the first,quarter ended March 31, 2008. In this ... US dollars., Q1 2008 Highlights, - ... 22% increase in SPY consumable ...
... could bring screening test or treatment , , MONDAY, May ... for its role in schizophrenia, also plays a significant part ... study finds. , Although the current study was done in ... be used as a test to identify women at risk ...
... 2008, CareToLive will,take to the streets with coast-to-coast protests ... and Tampa.,Joining us will be the Cancer Cure Coalition, ... Foundation of America. We are asking all patient,advocates to ... 6 men get prostate cancer. 75 American men die ...
... InfuSystem Holdings, Inc.,(OTC Bulletin Board: INHI; INHIW; INHIU), ... clinical services, today announced,financial results and provided a ... Mr. Steve Watkins, chief executive officer, commented, "We ... quarter of operations as a stand-alone,public company, and ...
... The American Veterinary,Medical Association (AVMA) has reinforced its ... and other equines by approving a,new policy on the ... the AVMA Executive Board on April 12, 2008,states that ... opposes the,use of double-deck trailers to transport equines. The ...
... Atrium Medical Corporation today,announced that it ... of,selected lots of HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic ... Thoracic,Catheters were manufactured with heparin found to ... The patient risk associated,with the presence of ...
Cached Medicine News:Health News:Novadaq Reports Financial Results for the First Quarter of 2008 2Health News:Novadaq Reports Financial Results for the First Quarter of 2008 3Health News:Novadaq Reports Financial Results for the First Quarter of 2008 4Health News:Novadaq Reports Financial Results for the First Quarter of 2008 5Health News:Novadaq Reports Financial Results for the First Quarter of 2008 6Health News:Novadaq Reports Financial Results for the First Quarter of 2008 7Health News:Novadaq Reports Financial Results for the First Quarter of 2008 8Health News:Novadaq Reports Financial Results for the First Quarter of 2008 9Health News:Novadaq Reports Financial Results for the First Quarter of 2008 10Health News:Novadaq Reports Financial Results for the First Quarter of 2008 11Health News:Gene May Be Key to Pregnancy Complication 2Health News:Gene May Be Key to Pregnancy Complication 3Health News:FDA Says, 'Wait' To Dying Men; Coast-To-Coast Prostate Cancer Demonstrations on May 30th in Protest of FDA Failure to Approve Safe, Effective Immunotherapy 2Health News:FDA Says, 'Wait' To Dying Men; Coast-To-Coast Prostate Cancer Demonstrations on May 30th in Protest of FDA Failure to Approve Safe, Effective Immunotherapy 3Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 2Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 3Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 4Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 5Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 6Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 7Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 8Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 9Health News:AVMA Opposes Use of Double-Deck Trailers for Transporting Horses and Other Equines 2Health News:Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters Used for Autotransfusion During Cardiopulmonary Bypass Surgery 2
(Date:1/15/2014)... TORONTO , Jan. 15, 2014  According to ... medical technology market intelligence, the United ... occlusion (TEO) device markets will expand moderately through ... fastest-growing segments. In particular, increasing interest in drug-eluting ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... available in its catalogue: ... for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North ... sellers of high-value chemistry, will hold the 30 th ... Beach Convention Center from January 21-24. ... attendees from top pharmaceutical, fine chemical and specialty chemical companies ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... 1, 2011 Chimerix, Inc., a pharmaceutical company developing ... that Kenneth I. Moch, President and Chief Executive Officer, ... Health Care Conference on March 8, 2011, 1:30 pm ... Massachusetts. The Cowen and Company Health Care Conference is ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that ... present a company update at the Cowen Health Care Conference in ... Interested parties may access a live audio webcast of ... www.BMRN.com .  A replay of the call will be archived ...
Cached Medicine Technology:Chimerix to Present at Cowen and Company 31st Annual Health Care Conference 2Chimerix to Present at Cowen and Company 31st Annual Health Care Conference 3BioMarin to Present at the Cowen Health Care Conference 2
The Carl Zeiss Head-worn Loupes L and LC are the ideal solution if a low magnification suffices for your work and you want to keep your hands free to perform the task at hand....
... delivers higher magnification for advanced surgical procedures. ... even at the highest magnification. 3.5x, 4.5x ... precise color rendition is ideal for surgical ... coating produce a superior image. The compact ...
... XL Advantage delivers higher magnification for advanced ... true image, even at the highest magnification. ... clarity and precise color rendition is ideal ... an anti-reflective coating produce a superior image. ...
... Made up of doublet objective and ... 2.0x, 2.5x and 3.0x. The true benefit ... Movement whilst maintaining focal clarity is made ... field. The ultra lightweight aluminum bar and ...
Medicine Products: